Crystal structure of HLA-G: a nonclassical MHC class I molecule expressed at the fetal-maternal interface - PubMed (original) (raw)

Crystal structure of HLA-G: a nonclassical MHC class I molecule expressed at the fetal-maternal interface

Craig S Clements et al. Proc Natl Acad Sci U S A. 2005.

Abstract

HLA-G is a nonclassical major histocompatibility complex class I (MHC-I) molecule that is primarily expressed at the fetal-maternal interface, where it is thought to play a role in protecting the fetus from the maternal immune response. HLA-G binds a limited repertoire of peptides and interacts with the inhibitory leukocyte Ig-like receptors LIR-1 and LIR-2 and possibly with certain natural killer cell receptors. To gain further insights into HLA-G function, we determined the 1.9-A structure of a monomeric HLA-G complexed to a natural endogenous peptide ligand from histone H2A (RIIPRHLQL). An extensive network of contacts between the peptide and the antigen-binding cleft reveal a constrained mode of binding reminiscent of the nonclassical HLA-E molecule, thereby providing a structural basis for the limited peptide repertoire of HLA-G. The alpha3 domain of HLA-G, a candidate binding site for the LIR-1 and -2 inhibitory receptors, is structurally distinct from the alpha3 domains of classical MHC-I molecules, providing a rationale for the observed affinity differences for these ligands. The structural data suggest a head-to-tail mode of dimerization, mediated by an intermolecular disulfide bond, that is consistent with the observation of HLA-G dimers on the cell surface.

PubMed Disclaimer

Figures

Fig. 1.

Fig. 1.

Overview of the structure of HLA-G. (A) The hc is shown in purple, β2M in blue, and the peptide in green. The position of the Cys-42 → Ser mutation is labeled. (B) Conformation of bound peptide. The corresponding 2_F_o - _F_c electron density is shown in mesh format. The peptide is in ball-and-stick format with each amino acid labeled.

Fig. 2.

Fig. 2.

Sequence alignment of human HLA-G with HLA-E, -A2, -B44, and -CW3 as well as mouse Qa-2. The sequence alignment is divided into the three domains: α1, α2, and α3. Residues highlighted with red have 100% identity. Residues highlighted in yellow are conservatively substituted. The secondary structure of HLA-G is illustrated directly above the sequence alignment. Orange arrows indicate β-strands, and blue cylinders indicate α-helices. Residues directly interacting with the peptide are marked with a large green star, and residues interacting only via a water molecule are marked with a hollow circle (see Table 3). The loop in domain α3 involved in LIR-1/2 (ILT-2/4) binding is highlighted with a green box.

Fig. 3.

Fig. 3.

Comparison of MHC-I bound peptides. The conformations of peptides bound by HLA-G (purple), HLA-E (48) (red), HLA-A2 (49) (yellow), and Qa-2 (39) (green) are shown in a side view (A), top view (B), and a view showing the main chain interactions between the epitope and the HLA-G hc (C). Polar interactions are depicted only (dashed lines); water molecules are shown in blue spheres.

Fig. 4.

Fig. 4.

Pocket-mediated interactions of HLA-G. HLA-G residues are shown in purple, peptide residues are shown in green, polar contacts are depicted as dashed lines, and water molecules are shown as blue spheres. (A) Pockets A and B mediating interactions with P1-Arg and P2-Ile, respectively. (B) Pockets C and D mediating interactions with P6-His and P2-Pro, respectively. (C) Pockets E and F mediating interactions with P7-Leu and P9-Leu, respectively. (D) Overview of the hydrophobic nature of the HLA-G binding cleft. Hydrophobic regions of the cleft that bind peptide are shown in green with the important anchor residue His-70 colored yellow. The pockets are labeled A–F, and the peptide is depicted as a ball-and-stick structure.

Fig. 5.

Fig. 5.

HLA-G may bind to LIR-1 (ILT-2) with enhanced affinity and undergo disulfide-bond-mediated dimerization. (A) Comparative analysis of the candidate ILT-2 binding site on the α3 domain of HLA-G (purple) and the equivalent binding site on HLA-A2 (yellow). (B) Model of the HLA-G dimer, looking down onto the antigen-binding cleft; peptides are in red (A protomer, light gray) and pink (B protomer, dark gray). The dimerization site is mediated via an intermolecular Cys-42–Cys-42 disulfide, indicating that the protomers within the dimer cannot adopt a side-by-side arrangement. However, a head-to-tail HLA-G dimer would satisfy the requirements for a Cys-42-mediated dimer, in which the loops containing the Cys-42 would clasp onto each other. In this plausible configuration, intermolecular interactions mediated via the β2M domains are possible. LIR-1 has been solved in complex with HLA-A2 (Protein Data Bank ID code 1P7Q), in which the LIR-1 binding site onto the α3 domain of the hc was mapped. Given the similarities between HLA-G and HLA-A2, the molecular organization of the HLA-G/ILT2 complex can be postulated in this HLA-G dimeric arrangement (ILT2 in blue and cyan).

Similar articles

Cited by

References

    1. Margulies, D. & McCluskey, J. (2003) in Fundamental Immunology, ed. Paul, W. (Lippincott, Philadelphia).
    1. Bjorkman, P. J. & Parham, P. (1990) Annu. Rev. Biochem. 59, 253-288. - PubMed
    1. O'Callaghan, C. A. & Bell, J. I. (1998) Immunol. Rev. 163, 129-138. - PubMed
    1. Gao, G. F., Willcox, B. E., Wyer, J. R., Boulter, J. M., O'Callaghan, C. A., Maenaka, K., Stuart, D. I., Jones, E. Y., Van Der Merwe, P. A., Bell, J. I. & Jakobsen, B. K. (2000) J. Biol. Chem. 275, 15232-15238. - PubMed
    1. Rammensee, H. G., Falk, K. & Rotzschke, O. (1993) Annu. Rev. Immunol. 11, 213-244. - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources